Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Alaunos Therapeutics Inc
TCRTCurrent price
1.98 USD
-0.035 USD (-1.75%)
Last closed
2.02 USD
Company
www.alaunos.com
ISIN
US98973P1012
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 266 550 USD
Yield for 12 month
-86.44 %
1Y
3Y
5Y
10Y
15Y
TCRT
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell therapies (TCR-T) to treat multiple solid tumor types. It develops Library TCR-T Cell Theraphy, which is in Phase I/II clinical trial for 12 TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. The company is also developing hunTR, a human neoantigen TCR discovery engine; and Sleeping Beauty Gene Transfer Platform, a non-viral genetic engineering technology. The company was founded in 2003 and is headquartered in Houston, Texas. Address: 2617 Bissonnet Street, Houston, TX, United States, 77005
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.75 USDP/E ratio
–Dividend Yield
–Current Year
+5 000 USD
Last Year
+2 922 000 USD
Current Quarter
+4 000 USD
Last Quarter
+1 000 USD
Current Year
-2 310 000 USD
Last Year
+163 000 USD
Current Quarter
+3 000 USD
Last Quarter
-1 000 USD
Key Figures TCRT
1 year
3 years
5 years
10 years
EBITDA
-12 579 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-51.76 %
PEG Ratio
–
Return On Equity TTM
-150.5 %
Wall Street Target Price
1.75 USD
Revenue TTM
7 000 USD
Book Value
2.36 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-19 596 000 USD
Earnings per share
-319.97 USD
Diluted Eps TTM
-319.97 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics TCRT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TCRT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
18.07.2024
Dividend Date
–
Stock Valuation TCRT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
724.3565
Price Sales TTM
466.65
Enterprise Value EBITDA
-3.5452
Price Book MRQ
0.8662
Financials TCRT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TCRT
For 52 weeks
2 USD
32.85 USD
50 Day MA
2.57 USD
Shares Short Prior Month
130 686
200 Day MA
10.11 USD
Short Ratio
4.56
Shares Short
132 342
Short Percent
9.6 %
BeatStart